The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
|
Activity Number:
|
619
|
|
Type:
|
Contributed
|
|
Date/Time:
|
Thursday, August 2, 2012 : 8:30 AM to 10:20 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #306261 |
|
Title:
|
Use of Order-Restricted Simultaneous Inferences in Clinical Dose Study Data Analysis
|
|
Author(s):
|
Gang Jia*+
|
|
Companies:
|
Merck Research Laboratories
|
|
Address:
|
, , ,
|
|
Keywords:
|
dose study ;
Simultaneous Inferences ;
Phase II ;
dose response
|
|
Abstract:
|
Clinical dose study is an important part of drug development. A Phase II clinical dose trial usually studies the drug efficacy at multiple dose levels and is usually conducted on a number of fixed dose levels. In many cases, drug response can be assumed to be monotone increasing or decreasing on dosage. Parametric dose response form is usually not appropriate besides monotone assumption due to: 1. there are not enough dose levels for reliable estimate of parametric function, 2. estimate of drug effect at extreme dose range are least accurate, and 3. there is usually no prior information on dose response shape. The order-restricted simultaneous inferences help to provide information on potential treatment efficacy and effect size, which are used to plan and design Phase III study.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.